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An Examination of the HBB Gene in Various African Populations
Abstract
Malarial resistance serves as a prime example of how infectious disease and parasite loads have affected human
evolutionary biology. Claiming over 1 million deaths worldwide every year, malaria's wide and severe effects
on the human condition are undeniably strong. However, studies on populations existing in malaria endemic
areas have revealed numerous biological adaptations that confer resistance against the disease. Major forms of
genetic resistance to malaria are seen through variants involved in sickle cell disease, Duffy blood antigens,
glycophorins, blood type groupings, and glucose-6-dehydrogenase deficiency. Of these the best studied are
the genetic variants in the HBB gene, which is responsible for the construction of hemoglobin in erythrocytes.
Variants of the HBB gene include HbS, HbC, HbE, and variants involved in beta-thalassemias, which are
present at varying frequencies in different areas of the world in response to the pressure of malarial disease.
African populations in particular are of great interest due to their greater genetic diversity and the high rates of
malarial diseases reported in African countries. As such, sequencing the genotypes of multiple African
populations would give a greater understanding to the frequencies of the two major HBB variants present in
Africa, HbS and HbC. Furthermore, given the strong selective pressure an infectious disease such as malaria
would place on populations in malaria-endemic regions, it is possible that multiple variants may have evolved
in these populations in attempt to combat the disease. By sequencing the HBB gene and its corresponding
upstream region in 260 individuals from 15 different African populations, the frequencies of the HbS and
HbC SNPs have been determined.
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Abstract 
Malarial resistance serves as a prime example of how infectious disease and parasite 
loads have affected human evolutionary biology. Claiming over 1 million deaths worldwide 
every year, malaria's wide and severe effects on the human condition are undeniably strong. 
However, studies on populations existing in malaria endemic areas have revealed numerous 
biological adaptations that confer resistance against the disease. Major forms of genetic 
resistance to malaria are seen through variants involved in sickle cell disease, Duffy blood 
antigens, glycophorins, blood type groupings, and glucose-6-dehydrogenase deficiency.  
Of these the best studied are the genetic variants in the HBB gene, which is responsible 
for the construction of hemoglobin in erythrocytes. Variants of the HBB gene include HbS, HbC, 
HbE, and variants involved in beta-thalassemias, which are present at varying frequencies in 
different areas of the world in response to the pressure of malarial disease. African populations in 
particular are of great interest due to their greater genetic diversity and the high rates of malarial 
diseases reported in African countries. As such, sequencing the genotypes of multiple African 
populations would give a greater understanding to the frequencies of the two major HBB variants 
present in Africa, HbS and HbC. 
Furthermore, given the strong selective pressure an infectious disease such as malaria 
would place on populations in malaria-endemic regions, it is possible that multiple variants may 
have evolved in these populations in attempt to combat the disease. By sequencing the HBB gene 
and its corresponding upstream region in 260 individuals from 15 different African populations, 
the frequencies of the HbS and HbC SNPs have been determined.  
 
 
Background Information 
The World Malaria Report has shown that there were about 219 million episodes of 
malaria and an estimated 660,000 deaths in the year 2011 among African populations, which 
bore over 90% of all reported malarial deaths (WHO, 2012).  Malaria caused by P. falciparum 
results in the highest morbidity and mortality accounting for almost over 1 million deaths every 
year, largely affecting children under the age of five. It has also been observed that many red cell 
disorders are more prominent in the tropical regions where malaria is endemic (Haldane et al., 
1949). The observation that erythrocytes with sickle cell trait hemoglobin are higher in regions 
with greater prevalence of malaria has been repeatedly confirmed.  It is also undisputable that the 
variant that causes the disease offers partial protection against severe malaria caused by P. 
falciparum (Aidoo et al., 2002).  Further research conducted by Allison (1954) confirmed that 
due to natural selection acting on the HBB gene, which codes for the production of beta 
hemoglobin in erythrocytes, the frequency of the sickle cell variant is significantly correlated 
with the geographic distribution of cases of malaria.   
The HBB (hemoglobin, beta) gene located on chromosome 11 contains 3 exons that 
provide the instructions for making a 146 amino acid long protein called beta globin which, 
along with alpha globin, makes up the hemoglobin molecule. The hemoglobin protein (molecular 
weight of about 64,500 g/mol) is an iron-containing molecule found in the red blood cells of all 
vertebrates (Perutz, 1978). Hemoglobin carries oxygen from the lungs and delivers it to the cells 
throughout the body. This molecule consists of two alpha (α) and two beta subunits (β), which 
are frequently referred to as alpha and beta hemoglobin, respectively. Each of these individual 
subunits carry an iron-containing molecule called a heme group which is responsible for the 
oxygen binding and delivery.  
More than 250 mutations in the HBB gene have been found to cause beta thalassemia 
while sickle cell anemia, a common form of sickle cell disease, is caused from the presence of a 
mutated form of hemoglobin.  The most common form of this disease, HbS, is an autosomal 
recessive disorder that causes significant morbidity and mortality particularly in those of African 
and Mediterranean ancestry.  Carriers of the sickle cell trait (who are heterozygous with one 
normal allele and one HbS allele) have some resistance to the fatal malaria caused by P. 
falciparum.  The sickle cell trait is caused by a single amino acid mutation (valine substituted in 
place of glutamic acid at the 6th position) in the beta chain of the HBB gene. While the 
inheritance of the sickle cell trait from both parents leads to the disease, individuals carrying only 
one copy of the allele are said to have some form of protection against malaria.  
Beyond the traditional sickle cell mutation (HbS) other mutations have been documented 
in the HBB gene such as HbC and HbE, which arose in Africa and Southeast Asia respectively 
(Clark and Higgins, 2006).  Malaria’s severe physiological effect on the survivability of human 
populations has caused strong evolutionary forces to act on affecting genes such as HBB, making 
them great targets for analysis of selective forces. Proximity to malaria-endemic locales plays an 
important role in the geographic distribution of several erythrocyte disorders like thalassemia, 
G6PD deficiency, sickle cell, and mutations in the Duffy gene. Malaria is significantly prevalent 
in many parts of the world in which mutations causing such disorders are still favored despite 
their physiological consequences, thus serving as a testament to the value of malarial resistance. 
For geographical regions with a low presence of malaria the frequency of these mutation alleles 
are low compared to malaria-endemic regions which vary from region to region but can 
potentially have carrier frequencies as high as 60% for HbS and 50% for HbC (Weatherall and 
Clegg, 2001), (WHO, 2006). Due to the strong selective force of malaria many typically 
deleterious mutations survive in the affected populations, which may result phenotypically as 
sickle cell and thalassemia depending on the mutation’s location (gene proper and gene 
promoter, respectively); thus, the strong selective pressure of malaria would make study of an 
associated gene such as HBB particularly informative (Ko et al., 2012).  
 
Materials and Methods 
Populations and DNA Samples 
DNA samples were obtained from 260 unrelated individuals arising from 15 different African 
populations.  These populations include Fulani, Lemande, Mada, Bakola pygmies from 
Cameroon; Yoruba from Nigeria; Iraqw, Sandawe, Datog and Hadza from Tanzania; Borana, 
Boni and Sengwer from Kenya, Chad and Sudan (Table 1). Samples were placed within the 
following categories denoted by their country and population of origins as well as a specific 
sample number: CAFU, CALM, CAMD, CAPL, CHBU, KEBN, KEBR, KELO, KESN, NGYR, 
SDBA, SDHD, TZDT, TZHZ, TZIQ, and TZSW.  
Ethics Statement 
The purpose of the study was well explained to all the participants before any consent forms 
were obtained.  Written inform consent forms were obtained from all individuals for blood 
collection and all subjects were kept anonymous.  Research and ethics consent were obtained 
from Commission for science and technology and the National Institute for Medical Research in 
Dares Salaam in Tanzania; Kenya Medical Research Institute in Nairobi, Kenya; the Ministry of 
Health and National Committee of Ethics, Cameroon.  Samples were collected and analyzed 
after obtaining approval from the Institutional Review Board of University of Pennsylvania.  
White blood cells were isolated from whole blood collected from each individual using a 
modified salting-out procedure. DNA was then extracted from these samples in the laboratory 
using a Gentra Purgen DNA extraction kit.  
Pre and Post Sequencing Technique 
The HBB gene (~ 1.6 kbp) encompassing exons 1, 2 and 3 was amplified using PCR.  An 
additional upstream region (~ 1kbp) from exon 1 was also amplified using specific primers 
(primer list in appendix).  In the PCR mixture each reaction contains 17.8uL of ddH2O, 2.5uL 1x 
PCR buffer, 1 uL 2.0mM of Mgso4, 0.2uL of Taq polymerase High Fidelity (Invitrogen), 0.5uL 
0.2 mM of dNTP (Promega), 0.5ul of 0.3uM of each primer and 2ul (50 ng) of genomic DNA 
(final volume 25 µl).  PCR cycles consisted of 1 cycle of pre-incubation (94ºC for 1 minute), 35 
cycles of amplification (95 ºC for 30 seconds, 58 ºC for 30 seconds, and 68 ºC for 2 minutes and 
30 seconds), and 1 cycle of extension (72 ºC for 5 minutes).  PCR products were examined by 
electrophoresis on 1% agarose gels in 1X TBE buffer pH 8.3.  PCR products were then cleaned 
using Shrimp Alkaline Phosphatase and Exonuclease 1 procedure (United States Biochemicals). 
Samples were then cleaned by an isopropanol procedure using 40uL 75% isopropanol and then 
75uL 70% isopropanol. Samples were re-suspended with 10uL of ABI HiDi Formamide and then 
sequenced by ABI 96 capillary 3730 XL sequencer (Applied Biosystems).  The contigs were 
assembled and the SNPs were identified using the Sequencer 4.10 program (Gene Codes 
Corporation). Coverage for the sequences was low; 2.5X average coverage for the gene exon and 
introns and 1.5X average coverage for the upstream region. The Reference gene was obtained 
from Genebank.  
 
 
 
Results 
 The results are divided into the 16 distinct populations given earlier. The frequency of the 
SNPs strongly associated with malarial resistance in Africa, HbS and HbC, and the number of 
individuals for each population are presented in Table 1. The same data is shown in graphical 
form in Figure 1.  
 
 
  
Table 1 Frequencies of Malaria Associated SNPs in human African populations 
Populations N HbS frequency (%) HbC frequency (%) 
CAFU 18 5.56 0 
CALM 18 11.11 0 
CAMD 18 5.56 0 
CAPL 19 0 0 
CHBU 11 9.09 0 
KEBN 16 1.25 6.25 
KEBR 17 29.41 17.65 
KELO 17 29.41 0 
KESN 19 0 0 
NGYR 16 6.25 0 
SDBA 8 25 1.25 
SDHD 11 27.27 18.18 
TZDT 17 23.53 11.76 
TZHZ 18 5.56 0 
TZIQ 18 5.56 0 
TZSW 19 15.79 5.26 
Total 260   
 
 
Figure 1. Histogram of HbS and HbC SNP frequencies in human African populations. N = 260. 
 
 
Discussion 
It is made evident from Table 1 that in the African populations examined HbS is the more 
frequent malaria associated SNP. All populations except CAPL and KESN reported some 
frequency for the HbS. Additionally, all populations reported a higher frequency of HbS than 
HbC except for KEBN. It should be noted that the presence of HbS and HbC is not mutually 
exclusive. In fact, many individuals are heterozygotes of HbSC, in which they have one allele of 
both variants, and suffer less severe phenotypic effects from this combination in relation to a 
homozygous HbS individual (Nagel et al., 2003). It is also particularly interesting that the 
populations of West Africa show very low frequencies of HbC, which is noted to be most 
significant in those of Yoruba and West African ancestry (Fairhurst et al., 2003), (Modiano et al., 
2003), (May et al., 2007). In contrast, it is actually the other regions of Africa such as Sudan, 
Kenya, and Tanzania that display the greatest frequencies of the HbC variant.  
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Future Directions 
 The first step forward with this project is to increase the coverage at which the samples 
were sequenced. Increasing the confidence of some of the data, especially in the upstream 
region, would allow for a more accurate portrayal of potential novel variants in the gene. 
Another endeavor would be to identify more functional variants on the HBB gene and on other 
erythrocyte-relevant genes among diverse ethnic groups in malaria-endemic regions.  Candidate 
variants can be identified either through population genetics-based analysis or through 
experimental/clinic measurements of their functional consequences (e.g., resistance to malaria 
susceptibility or deleterious effects causing various symptoms of hemoglobinopathy) (Rees et al., 
2010). The first approach would have some technical issues due to the segregation of these 
variants being at low frequencies in the sampled populations and thereby garnering low 
statistical power for detecting their selection signatures. In addition, the evolutionary origin of 
HbS and other variant alleles has been controversial because it is wide spread and many 
haplotype structures have been observed across different geographic ranges; as such, both single-
origin and multiple-origin hypotheses have gained some supports theoretically or empirically 
(Flint et al., 1993), (Flint et al., 1998). In general, future studies on the origin of HBB gene 
variants will help to understand how the human genome evolved to fight against 
infectious diseases (Barreiro and Quintana-Murci, 2009). 
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APPENDIX 
 
Primers were ordered from Integrated Data Technologies. 
 
Name   Primer 
 
HBB.F.1  5’ – GACAGGTACGGCTGTCATCA – 3’ 
 
HBB.R.1  5’ – GGTTTGAACTAGCTCTTCAT – 3’ 
 
HBB.F.3  5’ – ACATTTGCTTCTGACACAAC – 3’ 
 
HBB.R.3  5’ – AATCCAGCCTTATCCCAACC – 3’ 
 
HBB.NF  5’ – ATTCTGGAGACGCAGGAAGA – 3’ 
 
HBB.NR1  5’ – TATCTCTTGGCCCCATACCA – 3’ 
 
HBB.NR2  5’ – TAGATGGCTCTGCCCTGACT – 3’ 
 
HBB.S   5’ – CTGGATTATTCTGAGTCCAAGC – 3’ 
 
HBB.int_F  5’ – GATCCATCTACATATCCCAAA – 3’ 
 
HBB.int_R  5’ GGCAGAGAGAGTCAGTGCCTA – 3’ 
 
HBB.int2_F  5’ – GTGTACACATATTGACCAAATCAGGGTA – 3’ 
 
HBB.UP.F1  5’ – GGAACACTGAGACCCTACGC – 3’ 
 
HBB.UP.SEQ.R1 5’ – CGATCACGTTGGGAAGCTAT – 3’ 
 
HBB.UP.SEQ.R2 5’ – CTCTTCCTGCGTCTCCAGAA – 3’ 
 
 
